Apnimed
Tracy Klopfer has a diverse background in clinical research and program coordination. Currently serving as a Clinical Trial Manager at Apnimed since December 2020, Tracy previously held positions at Johns Hopkins School of Medicine from October 2014 to December 2020, including Research Program Coordinator and Research Program Assistant. Earlier experience includes a role as Bid Coordinator at Mid-Atlantic Air, Inc. from February 2014 to October 2014. Tracy's career reflects a strong commitment to advancing clinical research and program management.
This person is not in any offices
Apnimed
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.Sleep apnea is a common, serious condition with significant morbidity, increased mortality, and substantial effects on daily functioning. Sleep apnea affects more than 20 million Americans and has seriousconsequences. OSA is caused by a combination of predisposing anatomical factors and sleep-related decrements of activity in upper airway muscles.Current treatments primarily rely on positive pressure devices, e.g., CPAP, to maintain airway patency. Less commonly used treatments include mandibular advancement devices, nerve stimulation, and surgical interventions.Apnimed was founded in 2017 and is located in Cambridge, Massachusetts.